Supplementary Figure S1 from Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma
Year: 2024
Type: supplementary-materials
Abstract: Supplemental Figure 1. Overall survival for patients with GBM stratified by seizure at presentation (A), lymphopenia prior to chemoradiation (B), venous thromboembolism (C), pseudoprogression (D) and early progression (E). Adverse events associated with decreased overall survival were PsP (HR: 1.49, 95% CI: 1.01-2.22, p=0.046), VTE (HR: 1.42, 95% CI: 1.06-1.89, p=0.019) and early progression (HR: 3.83, 95% CI: 2.96-4.94, p<0.001).
Authors: Mary Jane Lim-Fat, J. Bryan Iorgulescu, Rifaquat Rahman, Varun Bhave, Alona Muzikansky, Eleanor Woodward, Sydney Whorral, Marie Allen, Mehdi Touat, Xiaomei Li, Gongwen Xy, Jay Patel, Elizabeth R. Gerstner, Jayashree Kalpathy-Cramer, Gilbert Youssef, Ugonma Chukwueke, J. Ricardo McFaline-Figueroa, Lakshmi Nayak, Eudocia Q. Lee, David A. Reardon, Rameen Beroukhim, Raymond Y. Huang, Wenya Linda Bi, Keith L. Ligon, Patrick Y. Wen
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4393382952